Articles

Podcasts

Videos

SEXUALLY TRANSMITTED DISEASES

A recent study looked at the racial disparities amongst people living with HIV and COVID-19 positivity rates.  

Examining a Connection Between HIV, COVID-19, and Race

2020 forced clinicians and people with HIV (PWH) to adapt to the COVID-19 pandemic. While initially it had an immediate impact on patient care, new solutions and strategies were created to ensure health care was delivered to those who needed it.

HIV Clinical Care This Past Year

Two randomized trials involved more than 4500 patients to determine the efficacy of a broadly neutralizing antibody in blocking acquisition of HIV infection.  

HIV Blocked in Part with Broadly Neutralizing Antibody  

A new cohort assessment evidences a disparity in weight-related outcomes with the ART regimens at 18 months.

Tenofovir Disoproxil Fumarate Linked to Less HIV Metabolic, BMI Risk than Tenofovir Alafenamide

The phase 2b-3 trial analyzing the efficacy of the ALVAC–gp120 regimen showed that it did not prevent an HIV-1 infection among the participants in the study at 24 months.

ALVAC–gp120 Regimen Does Not Prevent HIV-1 Infection in South African Trial

Long-acting injectables for latent and active tuberculous (TB) might be a treatment option in the future and could open up the door to possibly bundling HIV and TB care together. 

Applying the HIV Treatment Model to TB

A comparative study of same-day and seven-day TB test results show there is little difference in HIV treatment adherence or outcomes at 48 weeks.

Tuberculosis Testing in New HIV Patients Does Not Effect ART Regimen

Phase 1/2 trial results showed the immunomodulary vaccine regimen could induce significant T-cell response in patients with HIV.

HTI Vaccine Regimen Shows Immunogenicity in HIV Patients

Managing mental health in adults living with HIV is paramount during the COVID-19 pandemic.

Improving Mental Health in Older Adults Living With HIV

Index testing declined in countries including Malawi, Lesotho and Zimbabwe.

HIV / AIDS